TORRENT PHARMACEUTICALS L Intrinsic Value

TORNTPHARM · Healthcare · Current price ₹4,954

Full stock page
DocStoX fair value
₹1,780
low confidence
Current price
₹4,954
Upside to fair value
-64.1%
Verdict
Avoid
Quality score
5.0 / 10
Model it yourself — Intrinsic Value Calculator
Opens pre-filled with TORRENT PHARMACEUTICALS L's latest numbers.

Is TORRENT PHARMACEUTICALS L undervalued?

DocStoX estimates the fair value of TORRENT PHARMACEUTICALS L at ₹1,780 per share, versus the current market price of ₹4,954. That puts the stock about -64.1% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 4 independent methods: Residual income (₹385), Relative P/E (₹2,500), Graham floor (₹597), Analyst target (₹5,284). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹385 (bear) to ₹1,780 (base) to ₹5,284 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Margin of safety

Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹4,954 versus an intrinsic value of ₹1,780, TORRENT PHARMACEUTICALS L currently offers -64.1% of negative margin (i.e. a premium).

More on TORRENT PHARMACEUTICALS L

Fair ValueDCFValuationFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.